| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S Battersby, A D Ogilvie, C A Smith, D H Blackwood, W J Muir, J P Quinn, G Fink, G M Goodwin, A J Harma. Structure of a variable number tandem repeat of the serotonin transporter gene and association with affective disorder. Psychiatric genetics. vol 6. issue 4. 1997-07-07. PMID:9149321. |
the findings support the hypothesis that allelic variation in the serotonin transporter gene may contribute to susceptibility for both major depression and bipolar disorder. |
1997-07-07 |
2023-08-12 |
Not clear |
| C Bouwer, D J Stei. Buspirone is an effective augmenting agent of serotonin selective re-uptake inhibitors in severe treatment-refractory depression. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. vol 87. issue 4 Suppl. 1997-07-07. PMID:9180827. |
buspirone is an effective augmenting agent of serotonin selective re-uptake inhibitors in severe treatment-refractory depression. |
1997-07-07 |
2023-08-12 |
Not clear |
| H C Ko, R B Lu, I S Shiah, C C Hwan. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine. Biological psychiatry. vol 41. issue 7. 1997-06-25. PMID:9084896. |
this study was designed to investigate the relationship between platelet serotonin (5-ht) and plasma free 3-methoxy-4-hydroxyphenylglycol (mhpg) measures in depressed outpatients obtained from the same patient with unipolar depression during the pretreatment period and subsequent response to 6 weeks of treatment with either fluoxetine or maprotiline. |
1997-06-25 |
2023-08-12 |
Not clear |
| S J Ferrando, J D Goldman, W E Charnes. Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms. General hospital psychiatry. vol 19. issue 2. 1997-06-25. PMID:9097063. |
selective serotonin reuptake inhibitor treatment of depression in symptomatic hiv infection and aids. |
1997-06-25 |
2023-08-12 |
human |
| D J Goldstein, L A Corbin, K L Sundel. Effects of first-trimester fluoxetine exposure on the newborn. Obstetrics and gynecology. vol 89. issue 5 Pt 1. 1997-06-24. PMID:9166307. |
to determine whether first-trimester exposure to fluoxetine, a selective serotonin reuptake inhibitor commonly used to treat depression and obsessive-compulsive disorders, is associated with increased frequency of fetal malformations. |
1997-06-24 |
2023-08-12 |
Not clear |
| B E Leonar. Neurotransmitters in depression: noradrenaline and serotonin and their interactions. Journal of clinical psychopharmacology. vol 17 Suppl 1. 1997-06-19. PMID:9090572. |
neurotransmitters in depression: noradrenaline and serotonin and their interactions. |
1997-06-19 |
2023-08-12 |
Not clear |
| S Kindler, P N Dannon, I Iancu, Y Sasson, J Zoha. Emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors. Clinical neuropharmacology. vol 20. issue 2. 1997-06-18. PMID:9099464. |
emergence of kleptomania during treatment for depression with serotonin selective reuptake inhibitors. |
1997-06-18 |
2023-08-12 |
Not clear |
| J M Gorma. Comorbid depression and anxiety spectrum disorders. Depression and anxiety. vol 4. issue 4. 1997-06-18. PMID:9166648. |
antidepressant medications, including the selective serotonin reuptake inhibitors, tricyclic antidepressants, and monoamine oxidase inhibitors, are highly effective in the management of comorbid depression and anxiety. |
1997-06-18 |
2023-08-12 |
Not clear |
| A F Schatzber. Treatment of severe depression with the selective serotonin reuptake inhibitors. Depression and anxiety. vol 4. issue 4. 1997-06-18. PMID:9166650. |
treatment of severe depression with the selective serotonin reuptake inhibitors. |
1997-06-18 |
2023-08-12 |
Not clear |
| A F Schatzber. Treatment of severe depression with the selective serotonin reuptake inhibitors. Depression and anxiety. vol 4. issue 4. 1997-06-18. PMID:9166650. |
the selective serotonin reuptake inhibitors (ssris) are recognized as effective as and better tolerated than older antidepressant therapies and have become the drugs of choice in the treatment of mild to moderate depression. |
1997-06-18 |
2023-08-12 |
Not clear |
| G D Tollefson, M E Sayle. Course of psychomotor agitation during pharmacotherapy of depression: analysis from double-blind controlled trials with fluoxetine. Depression and anxiety. vol 4. issue 6. 1997-06-18. PMID:9166658. |
we analyzed data from blinded clinical trials involving 4,737 patients with major depression assigned to a selective serotonin reuptake inhibitor (fluoxetine), a comparator antidepressant (usually a tricyclic antidepressant [tca]), or placebo. |
1997-06-18 |
2023-08-12 |
Not clear |
| P D Hrdina, D Bakish, A Ravindran, J Chudzik, P Cavazzoni, Y D Lapierr. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry research. vol 66. issue 2-3. 1997-06-12. PMID:9075272. |
this study examined, in the largest sample of major depressives reported so far, platelet serotonergic parameters (5-ht uptake, [3h]paroxetine binding and 5-ht2a receptors measured by [3h]lsd binding) in 60 antidepressant-free depressed patients and 40 age- and gender-matched control subjects before treatment, and in 45 major depression patients during treatment with antidepressants. |
1997-06-12 |
2023-08-12 |
human |
| P D Hrdina, D Bakish, A Ravindran, J Chudzik, P Cavazzoni, Y D Lapierr. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry research. vol 66. issue 2-3. 1997-06-12. PMID:9075272. |
suppression of 5-ht uptake correlated with decreases in hamilton depression (hamd) scores. |
1997-06-12 |
2023-08-12 |
human |
| C Routledge, D N Middlemis. The 5-HT hypothesis of depression revisited. Molecular psychiatry. vol 1. issue 6. 1997-06-09. PMID:9154243. |
the 5-ht hypothesis of depression revisited. |
1997-06-09 |
2023-08-12 |
Not clear |
| J F Neumaier, F Petty, G L Kramer, P Szot, M W Hambli. Learned helplessness increases 5-hydroxytryptamine1B receptor mRNA levels in the rat dorsal raphe nucleus. Biological psychiatry. vol 41. issue 6. 1997-05-29. PMID:9066990. |
learned helplessness is a behavioral condition induced by exposure to inescapable stress that models aspects of stress-related disorders including depression and posttraumatic stress disorder, and has been associated with diminished serotonin release in the rat frontal cortex. |
1997-05-29 |
2023-08-12 |
rat |
| T A Zamoshchina, A S Saratikov, L N Maslov, A V Matveenk. [The effect of lithium chloride on the desynchronization of "reserpine-induced depression"]. Eksperimental'naia i klinicheskaia farmakologiia. vol 60. issue 1. 1997-05-28. PMID:9162278. |
for 10 days in the morning but not in the evening) prevented effectively desynchronization of "reserpine depression" in mice and rats: the spectra and structure of the rhythms of behavioral parameters (open field), body temperature, content of serotonin and its metabolites in the brain and that of glucocorticoids in blood plasma were almost the same as those in intact animals; the circadian harmony of all parameters were correlated in the best manner and their mean circadian values were restored. |
1997-05-28 |
2023-08-12 |
mouse |
| N J Carrey, D M Wiggins, R P Mili. Pharmacological treatment of psychiatric disorders in children and adolescents: focus on guidelines for the primary care practitioner. Drugs. vol 51. issue 5. 1997-05-22. PMID:8861545. |
selective serotonin (5-ht) reuptake inhibitors (ssris) appear to be safer for depression and are also useful in obsessive-compulsive disorder. |
1997-05-22 |
2023-08-12 |
Not clear |
| R T Joff. Tranylcypromine in recurrent brief depression: two case reports. International clinical psychopharmacology. vol 11. issue 4. 1997-05-22. PMID:9031997. |
these reports are of interest in light of recent data suggesting that this subtype of depression does not respond to conventional antidepressants such as selective serotonin reuptake inhibitors. |
1997-05-22 |
2023-08-12 |
Not clear |
| S Kitayama, T Doh. Cellular and molecular aspects of monoamine neurotransmitter transporters. Japanese journal of pharmacology. vol 72. issue 3. 1997-05-15. PMID:8957680. |
monoamine neurotransmitter transporters such as those for dopamine, norepinephrine and serotonin are of interest, since they are a target of drugs of abuse and are involved in neuronal disorders including parkinson's disease and depression. |
1997-05-15 |
2023-08-12 |
Not clear |
| E Prévot, C Maudhuit, E Le Poul, M Hamon, J Adrie. Sleep deprivation reduces the citalopram-induced inhibition of serotoninergic neuronal firing in the nucleus raphe dorsalis of the rat. Journal of sleep research. vol 5. issue 4. 1997-05-12. PMID:9065875. |
in light of the possible involvement of central serotonin (5-hydroxytryptamine, 5-ht) neurotransmission in both depression and sleep mechanisms, we presently investigated, in the rat, the effects of sd and recovery sleep on the electrophysiological response of 5-ht neurons in the nucleus raphe dorsalis (nrd) to an acute challenge with the 5-ht reuptake blocker citalopram. |
1997-05-12 |
2023-08-12 |
rat |